gt biopharma stock split

Split Factor- Latest On GT Biopharma Inc. The reverse split was a requirement of the.

Has Anyone Been Following Gtbp On Their Uplisting Today On Nasdaq And Reverse Split 17 1 R Robinhoodpennystocks

Includes date and ratio.

. On Tuesday September 13 2022. Stock Splits Market Cap Stock split history for GT Biopharma since 2022. Share your opinion and gain insight from other stock traders and investors.

Get GT Biopharma Inc GTBPNASDAQ real-time stock quotes news price and financial information from CNBC. GTBP stock discussion in Yahoo Finances forum. GT Biopharma shall have delivered evidence that it has taken all necessary corporate action to effectuate the GT Biopharma Stock Split and that the GT.

LOS ANGELES CA ACCESSWIRE August 21 2017 GT Biopharma Inc. Formerly known as Oxis International Inc announced today a 1-for-300 reverse stock split. See GT Biopharma Inc.

31 2022 GLOBE NEWSWIRE -- GT Biopharma Inc. After the completed reverse split there will be approximately 500000 shares of GT Biopharma stock issued and outstanding. According to analysts consensus price target of 1150 GT Biopharma has a forecasted upside of 5970 from its current price of 165.

The Company or GTB NASDAQ. In addition the Company effected a 1-for-17 reverse stock split and its common stock will begin trading on The Nasdaq Capital Market under the existing ticker symbol GTBP on a post. GT Biopharma Stock Split.

GTBP a clinical stage immuno-oncology company focused on developing. GT Biopharma announces reverse stock split. After the completed reverse split there will be approximately 500000 shares of GT Biopharma stock issued and outstanding.

Formerly known as Oxis International Inc announced today a 1-for-300 reverse stock split. Find the latest GT Biopharma Inc. Amount of Analyst Coverage GT.

BioWorld Science Other news to. Prior to the Closing Date GT Biopharma will reverse split its issued and outstanding shares on a one for three hundred basis the GT Biopharma Stock Split so. Using our proprietary platform technology GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia non-Hodgkins.

Upgrade your daily dose of biopharma and medtech news. The reverse split was a requirement of the. GTBP history of stock splits.

In addition the Company effected a 1-for-17 reverse stock split and its common stock will begin trading on The Nasdaq Capital Market under the existing ticker symbol GTBP. Split of GT Biopharma Shares. The latest price target for GT Biopharma NASDAQ.

Prices shown are actual historical values and are not adjusted for either splits or dividends. The analyst firm set a price target for 500 expecting. GTBP was reported by HC Wainwright Co.

LOS ANGELES CA ACCESSWIRE August 21 2017 GT Biopharma Inc. GT Biopharma shall have delivered evidence that it has taken all necessary corporate action to effectuate the GT Biopharma Stock Split and that the GT.

Gt Biopharma Inc 2021 Current Report 8 K